Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M605Revenue $M0.2Net Margin (%)--Altman Z-Score-41.8
Enterprise Value $M760EPS $-0.9Operating Margin %--Piotroski F-Score1
P/E(ttm)--Beneish M-Score-14.7Pre-tax Margin (%)--Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %-20.0Quick Ratio0.3Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %-13.2Current Ratio0.3Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-121.9Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M429ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with MNKD

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MNKDFirst Eagle Investment 2013-03-31 Sold Out -0.0066%$2.31 - $3.56
($2.75)
$ 1.41-49%Sold Out0
MNKDFirst Eagle Investment 2012-12-31 Buy 0.01%$1.85 - $2.83
($2.16)
$ 1.41-35%New holding800,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MNKD is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


MNKD: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Martens JuergenCorporate VP and COO 2015-05-21Buy20,000$4.57-69.15view
Edstrom HakanPresident & CEO 2015-04-24Sell73,460$4.83-70.81view
Edstrom HakanPresident & CEO 2015-03-27Sell73,460$5.21-72.94view
Martens JuergenCorporate VP and COO 2015-03-02Sell121,333$6.54-78.44view
Thomson DavidVP & General Counsel 2015-02-19Sell68,662$7.19-80.39view
Edstrom HakanPresident & CEO 2015-02-10Sell73,460$7.75-81.81view
Palumbo DianeVice President, Human Resource 2015-02-05Sell149,833$6.95-79.71view
Thomson DavidVP & General Counsel 2015-02-05Sell80,000$7-79.86view
Edstrom HakanPresident & CEO 2015-01-30Sell73,460$6.34-77.76view
Palumbo DianeVice President, Human Resource 2015-01-05Sell188,999$5.95-76.3view

Press Releases about MNKD :

Quarterly/Annual Reports about MNKD:

News about MNKD:

Articles On GuruFocus.com
Why MannKind Could Be a Value Trap Jan 04 2016 
MannKind Corporation Disappoints with Afrezza Sales; Analysts Lower Expectations May 11 2015 
MannKind Looks Good For Long Term Investors Apr 29 2015 
Analysts Weigh in on MannKind Following Q4 Results Feb 27 2015 
What to Watch for: November 3-7 Nov 04 2014 
Roche to Acquire InterMune and Deliver Hope to Patients Worldwide Aug 25 2014 
How Sanofi's Growth Strategy Will Catapult Afrezza Into a Blockbuster Drug Aug 20 2014 
Revisiting Arena, Orexigen, And VIVUS: Shareholders Can Recoup Their Losses By Invest In MannKind Aug 19 2014 
Evaluating MannKind (MNKD) & Sanofi (SNY) Agreement for Afrezza Aug 15 2014 
There is a Tide in the Affairs of MannKind: When Taken At the Flood, Will Lead to Fortune Aug 14 2014 

More From Other Websites
MANNKIND CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits May 04 2016
MannKind Corporation to Hold 2016 First Quarter Financial Results Conference Call on May 9, 2016 May 02 2016
MannKind Corporation to Hold 2016 First Quarter Financial Results Conference Call on May 9, 2016 May 02 2016
Why Traders Are Selling These Five Tanking Stocks? Apr 27 2016
Short Sellers Run for Cover From Major Biotechs Apr 27 2016
MannKind and Its CEO Fail Simple Financial Literacy Test Apr 27 2016
The 5 Most Shorted Nasdaq Stocks: Short Sellers Take a Breather Apr 27 2016
MANNKIND CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements... Apr 26 2016
Analyst Call Rescheduled to April 26, 2016 Apr 19 2016
Analyst Call Rescheduled to April 26, 2016 Apr 19 2016
MannKind Expands Commercial Capabilities With Two New Hires Apr 19 2016
MannKind Expands Commercial Capabilities With Two New Hires Apr 19 2016
Auditor warnings on large company solvency reach highest level since crisis Apr 13 2016
Markets Fall on Earnings Worry: Biotech Stocks Follow Suit Apr 13 2016
You Can’t Smooth The Bumps Apr 12 2016
Here’s Why These 5 Stocks Are on the Move Today Apr 12 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)